ASSET - a Double-Blind, Randomized Placebo-Controlled Clinical Investigation With Alteco® LPS Adsorber

NATerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

April 28, 2017

Study Completion Date

April 28, 2017

Conditions
Septic Shock
Interventions
DEVICE

Alteco LPS Adsorber

"Alteco® LPS Adsorber is a Class IIa medical device developed in accordance with existing international standards. Alteco® LPS Adsorber does not contain any pharmaceutical or toxic components.~Alteco® LPS Adsorber is used for the adsorption of LPS as endotoxins. The capturing component is a specially designed synthetic peptide developed for adsorption of endotoxin. The capturing component has high affinity to Lipid A, i.e. a constant component in the endotoxin molecule, which ensures efficient reduction of endotoxins from different bacterial species."

DEVICE

Placebo

Exactly the same as Alteco LPS Adsorber but no peptide component has been attached to the matrix (i.e. there is no adsorber functionality)

Trial Locations (6)

5021

Haukeland Universitetssykehus, Bergen

33521

Tampere University Hospital, Tampere

70210

Kuopio University Hospital, Kuopio

0372

Oslo Universitetssykehus, Oslo

SE-58185

Linköping University Hospital, Linköping

SE-751 81

Uppsala University Hospital, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

TFS Trial Form Support

INDUSTRY

collaborator

Uppsala University

OTHER

lead

Alteco Medical AB

INDUSTRY